Does DULOXETINE Cause Basal cell carcinoma? 7 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Basal cell carcinoma have been filed in association with DULOXETINE (Duloxetine Hydrochloride). This represents 0.0% of all adverse event reports for DULOXETINE.
7
Reports of Basal cell carcinoma with DULOXETINE
0.0%
of all DULOXETINE reports
0
Deaths
1
Hospitalizations
How Dangerous Is Basal cell carcinoma From DULOXETINE?
Of the 7 reports, 1 (14.3%) required hospitalization.
Is Basal cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DULOXETINE. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does DULOXETINE Cause?
Nausea (7,355)
Dizziness (6,983)
Drug withdrawal syndrome (6,503)
Headache (5,541)
Fatigue (5,309)
Insomnia (5,270)
Anxiety (4,973)
Paraesthesia (4,854)
Drug ineffective (4,829)
Hyperhidrosis (4,101)
What Other Drugs Cause Basal cell carcinoma?
ADALIMUMAB (1,547)
INFLIXIMAB (1,340)
METHOTREXATE (1,268)
RITUXIMAB (1,085)
ETANERCEPT (998)
ABATACEPT (852)
TOCILIZUMAB (761)
LENALIDOMIDE (685)
HYDROXYCHLOROQUINE (662)
LEFLUNOMIDE (657)
Which DULOXETINE Alternatives Have Lower Basal cell carcinoma Risk?
DULOXETINE vs DUPILUMAB
DULOXETINE vs DURAGESIC
DULOXETINE vs DUROGESIC
DULOXETINE vs DUROTEP MT
DULOXETINE vs DURVALUMAB